These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2455134)

  • 1. Mechanisms of action of calcium antagonists in hypertension.
    Kiowski W; Bolli P; Erne P; Hulthén UL; Bühler FR
    J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S23-8. PubMed ID: 2455134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Place of calcium antagonists in the treatment of hypertension.
    Kiowski W
    Cor Vasa; 1990; 32(2 Suppl 1):2-11. PubMed ID: 2200638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of action and clinical use of calcium antagonists in hypertension.
    Kiowski W; Bolli P; Erne P; Müller FB; Hulthén UL; Bühler FR
    Circulation; 1989 Dec; 80(6 Suppl):IV136-44. PubMed ID: 2557176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium antagonists in hypertension.
    Bühler FR; Kiowski W
    J Hypertens Suppl; 1987 Aug; 5(3):S3-10. PubMed ID: 3312526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodynamic and counterregulatory effects of calcium antagonists in hypertension.
    Kiowski W; Bolli P; Erne P; Hulthén UL; Müller FB; Bühler FR
    J Cardiovasc Pharmacol; 1988; 12 Suppl 6():S39-43. PubMed ID: 2468904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parallel reduction of calcium-influx-dependent vasoconstriction and platelet-free calcium concentration with calcium entry and beta-adrenoceptor blockade.
    Bolli P; Erne P; Hulthén UL; Ritz R; Kiowski W; Ji BH; Bühler FR
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S996-1001. PubMed ID: 6085391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of platelet calcium with blood pressure. Effect of antihypertensive therapy.
    Erne P; Bolli P; Bürgisser E; Bühler FR
    N Engl J Med; 1984 Apr; 310(17):1084-8. PubMed ID: 6143260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological basis for use of calcium antagonists in hypertension.
    Scriabine A; Kazda S
    Magnesium; 1989; 8(5-6):253-65. PubMed ID: 2693846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium antagonists and their potential for antihypertensive therapy.
    Bühler FR; Kiowski W
    Ann N Y Acad Sci; 1988; 522():584-99. PubMed ID: 3288062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recognizing and treating two types of long-term vasoconstriction in hypertension.
    Laragh JH; Resnick LM
    Kidney Int Suppl; 1988 Sep; 25():S162-74. PubMed ID: 3054233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of calcium-entry blockers and diuretics in the treatment of hypertensive patients.
    Sowers JR; Mohanty PK
    Circulation; 1987 Jun; 75(6 Pt 2):V170-3. PubMed ID: 3552313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitrendipine and other calcium entry blockers (calcium antagonists) in hypertension.
    Kazda S; Garthoff B; Knorr A
    Fed Proc; 1983 Feb; 42(2):196-200. PubMed ID: 6822291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and pharmacological properties of calcium antagonists in essential hypertension in humans and spontaneously hypertensive rats.
    Aoki K; Kawaguchi Y; Sato K; Kondo S; Yamamoto M
    J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S298-302. PubMed ID: 6184557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Calcium antagonists in the treatment of chronic arterial hypertension and hypertensive crisis].
    Brandt D
    Wien Med Wochenschr; 1983 Mar; 133(6):131-5. PubMed ID: 6134398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Are all antihypertensive drugs renoprotective?].
    Wolf S; Risler T
    Herz; 2004 May; 29(3):248-54. PubMed ID: 15167950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of calcium antagonists in the treatment of hypertension.
    Klaus D
    J Cardiovasc Pharmacol; 1992; 20 Suppl 6():S5-14. PubMed ID: 1283189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The hemodynamics of calcium-channel antagonists in hypertension: vascular and myocardial responses.
    Cody RJ
    Circulation; 1987 Jan; 75(1 Pt 2):I175-9. PubMed ID: 3791618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodynamic and antihypertensive treatment responses with calcium antagonists.
    Bolli P; Kiowski W; Erne P; Hulthén LU; Bühler FR
    J Cardiovasc Pharmacol; 1985; 7 Suppl 2():S126-30. PubMed ID: 2409361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute hypertension and calcium-channel blockers.
    Kanneganti M; Halpern NA
    New Horiz; 1996 Feb; 4(1):19-25. PubMed ID: 8689271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal protection in essential hypertension: how do angiotensin-converting enzyme inhibitors compare with calcium antagonists?
    Bauer JH; Reams GP
    J Am Soc Nephrol; 1990 Nov; 1(5 Suppl 2):S80-7. PubMed ID: 16989071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.